M. Ohiwa

发表

Elevated plasma tissue factor antigen level in patients with disseminated intravascular coagulation

H. Wada, S. Shirakawa, K. Deguchi, 1994, American journal of hematology.

Plasma thrombomodulin as a marker of vascular disorders in thrombotic thrombocytopenic purpura and disseminated intravascular coagulation

Tatsuya Hayashi, Koji Suzuki, H. Wada, 1992, American journal of hematology.

Hemostatic study before onset of disseminated intravascular coagulation

Koji Suzuki, H. Wada, S. Tamaki, 1993, American journal of hematology.

Increased activated protein C-protein C inhibitor complex levels in patients with pulmonary embolism.

J. Nishioka, H. Wada, T. Hayashi, 1994, Thrombosis and haemostasis.

Plasma level of tumor necrosis factor in disseminated intravascular coagulation

H. Wada, M. Takagi, M. Tanigawa, 1991, American journal of hematology.

Elevated plasma levels of vascular endothelial cell markers in patients with hypercholesterolemia

Koji Suzuki, H. Wada, M. Tanigawa, 1993, American journal of hematology.

Increased levels of vascular endothelial cell markers in thrombotic thrombocytopenic purpura

Tatsuya Hayashi, Koji Suzuki, H. Wada, 1993, American journal of hematology.

Increased vascular endothelial cell markers in patients with disseminated intravascular coagulation

Tatsuya Hayashi, Koji Suzuki, H. Wada, 1993, American journal of hematology.

Plasma Tissue Factor Antigen Level in Patients with Disseminated Intravascular Coagulation

H. Wada, S. Tamaki, S. Shirakawa, 1994 .

Plasminogen activators and their inhibitors in leukemic cell homogenates

Y. Kumeda, H. Wada, S. Tamaki, 1993, American journal of hematology.

Cyclic AMP in Leukemic Cell Lysate in Disseminated Intravascular Coagulation

H. Hidaka, T. Tanaka, Tohru Kobayashi, 1992 .

Disseminated mycobacterial infection in a hemophilia B patient with acquired immunodeficiency syndrome.

H. Wada, M. Tanigawa, S. Tamaki, 1990, Japanese journal of medicine.

Stimulation of tissue type plasminogen activator by leukaemic cell homogenates

Y. Kumeda, H. Wada, S. Shirakawa, 1993, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

Factor VII Mie: Homozygous Asymptomatic Type I Deficiency Caused by an Amino Acid Substitution of His (CAC) for Arg(247) (CGC) in the Catalytic Domain

Tatsuya Hayashi, Koji Suzuki, H. Wada, 1994, Thrombosis and Haemostasis.

Hypercoagulable state in patients with hypercholesterolemia: effects of pravastatin.

H. Wada, S. Tamaki, K. Deguchi, 1992, Clinical therapeutics.

Plasma cytokine levels in thrombotic thrombocytopenic purpura

H. Wada, M. Tanigawa, S. Tamaki, 1992, American journal of hematology.

Tissue Type Plasminogen Activator Antigen in Disseminated Intravascular Coagulation

Y. Kumeda, H. Wada, M. Takagi, 1991 .

A Compound Heterozygous Protein C Deficiency with a Single Nucleotide G Deletion Encoding Gly-381 and an Amino Acid Substitution of Lys for Gla-26

Tatsuya Hayashi, J. Nishioka, M. Ido, 1993, Thrombosis and Haemostasis.

Hemostatic Abnormality of Hemophagocytic Syndrome

H. Wada, R. Yatani, K. Kita, 1991 .

[Elevated plasma interleukin-6 in patient with idiopathic thrombocytopenic purpura].

H. Wada, M. Takagi, S. Tamaki, 1991, [Rinsho ketsueki] The Japanese journal of clinical hematology.

Increased plasma level of interleukin‐6 in disseminated intravascular coagulation

T. Noguchi, M. Tanigawa, K. Deguchi, 1993, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

Treatment of disseminated intravascular coagulation with gabexate mesilate.

H. Wada, S. Tamaki, M. Shimura, 1993, Clinical therapeutics.